: Our current work's primary goal is to create novel heterogeneous gallium sulfide (Ga2S3) nanocatalysts and investigate their catalytic activity in the synthesis of 3,3-(arylmethylene)-bis-(4- hydroxycoumarin) derivatives without use of solvent. FT-IR, XRD, SEM, and EDX analysis characterized the synthesized gallium sulfide (Ga2S3) nanomaterial catalysts. This method's main benefits are its short reaction time, solvent-free conditions, extremely mild reaction conditions, good product yield, and, most importantly, its ability to recover catalysts after at least four runs.
No takes yet. Share an insight, caveat, or question.
Parhad et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: